The Crosetto Foundation for the Reduction of Cancer Deaths has issued an urgent appeal to Members of the European Parliament to intervene in the allocation of CERN's funding. The foundation argues that for over 30 years, CERN has misallocated public funds by not adopting Dario Crosetto's 3D-Flow technology, a move that could have saved billions and significantly advanced both particle physics and medical imaging technologies.
Crosetto's 3D-Flow architecture, recognized as a breakthrough in 1993, offers unparalleled efficiency in processing ultra-high-data streams, with applications ranging from particle detection at CERN to early cancer diagnosis through 3D-CBS technology. Despite its proven superiority and cost-effectiveness, CERN has continued to invest in FPGA-based systems, which have repeatedly failed to meet performance requirements, leading to unnecessary expenditure of taxpayer money.
The foundation's call to action underscores the potential for 3D-Flow technology to revolutionize not only scientific research but also healthcare, by enabling early detection of diseases at a fraction of current costs. The lack of a technical rebuttal from the scientific community to Crosetto's findings further highlights the need for transparency and accountability in the allocation of research funding.
This situation presents a critical opportunity for MEPs to ensure that public funds are used efficiently, fostering innovations that can save lives and reduce healthcare costs. The Crosetto Foundation's appeal is a reminder of the importance of scientific integrity and the role of oversight in maximizing the societal benefits of research investments.
